Few studies have addressed racial differences in prostate cancer (PCa) detection between Western and Arabian countries, although PCa has a significantly lower prevalence in Arabic populations compared to Western populations.
Therefore, an explanation of this difference is lacking. Serum prostate-specific antigen (PSA) is a valuable marker used to select patients who should undergo prostate biopsies, although the manner in which it is used may require adjustments based on the ethnic population in question. We investigated racial differences in the PCa detection rate between Canadian and Saudi populations. A retrospective analysis was performed of data collected prospectively over 5 consecutive years in urology clinics at the McGill University Health Center (MUHC) and King Saud University Hospital (KSUH). Men who had high (>4'ng/mL) or rising PSA levels and a negative digital rectal examination were eligible. A total of 1403 Canadian and 414 Saudi patients were evaluated for the study; 717 and 158 men, median age 64 and 68 years, were included in the MUHC and KSUH cohorts, respectively, P< 0.0001). Median serum PSA, prostate volume, and PSA density values were 6.1'ng/mL, 47.3 g, and 0.12'ng·mL-1·g-1, respectively, for MUHC patients and 5.2'ng/mL, 64.5'g, and 0.08'ng·mL-1·g-1, respectively, for KSUH patients (P< 0.0001, t-test followed by one-way ANOVA). In addition, the KSUH group had a significantly lower PCa detection rate among patients younger than 60 years of age and with PSA values < 10'ng/mL.
Written by:
Al-Abdin OZ, Rabah DM, Badr G, Kotb A, Aprikian A. Are you the author?
King Saud University, College of Medicine, Department of Urology/Surgery, Riyadh, Saudi Arabia; Department of Urology/Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Reference: Braz J Med Biol Res. 2013 Jul 2;46(6):0.
doi: 10.1590/1414-431X20132757
PubMed Abstract
PMID: 23802226
UroToday.com Prostate Cancer Section
